The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Diamox 250 mg Tablets

Amdipharm LimitedPA1142/020/003

Main Information

Trade NameDiamox 250 mg Tablets
Active SubstancesAcetazolamide
Dosage FormTablet
Licence HolderAmdipharm Limited
Licence NumberPA1142/020/003

Group Information

ATC CodeS01EC Carbonic anhydrase inhibitors
S01EC01 acetazolamide


Licence Issued01/04/1978
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceConditions: None Commitment: Continuation of stability data on batch nos. 63464, 63846 & 63847 till the end of registered shelf life for Diamox Tablets 250mg and to provide stability data to IMB once available and report any out of specifications results with proposed action.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back